To perform loss of function experiments, we isolated several monoclones of HNSCC OBC01 cells after endogenous EHF was knocked out by CRISPR/Cas9 techniques using commercially available gRNA against the EHF gene. The gene discussed is EHF; the disease is head and neck squamous cell carcinoma.